Skip to main content
大禹生物 logo

大禹生物 — Investor Relations & Filings

Ticker · 920970 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 384 across all filing types
Latest filing 2025-11-13 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920970

About 大禹生物

http://www.sxdysw.cn/

Shanxi Dayu Biological Assistance Co., Ltd. specializes in the research, development, and production of advanced animal nutrition and health solutions. The company focuses on the manufacturing of feed additives, micro-ecological preparations, and biological feed products. Its core portfolio includes probiotics, enzyme preparations, and functional premixes designed to enhance livestock immunity, improve feed conversion rates, and promote sustainable farming practices. By leveraging biotechnology, the firm provides integrated solutions for the aquaculture and animal husbandry sectors, emphasizing scientific innovation and product quality to support the modernization of the agricultural supply chain.

Recent filings

Filing Released Lang Actions
上海市锦天城律师事务所关于山西大禹生物工程股份有限公司2025年第五次临时股东会的法律意见书
Regulatory Filings Classification · 85% confidence The document is a legal opinion letter (“法律意见书”) issued by an external law firm regarding the convening, procedures, and voting at an extraordinary shareholders’ meeting. It does not itself constitute a financial report or meeting notice by the company, nor is it a proxy solicitation or a standard meeting transcript. Instead, it is an attestation by attorneys on the legality of the meeting and its results. Under the “CERTIFICATION RULE,” such an attestation or legal opinion gets classified as a general regulatory filing. Thus, the best fit is Regulatory Filings (RNS).
2025-11-13 Chinese
公司章程
Governance Information Classification · 100% confidence The document is titled "公司章程" which translates to "Company Articles of Association" or "Company Bylaws." It contains detailed provisions about the company's organization, shareholder rights, board of directors, management, financial accounting, profit distribution, audit, meetings, and other governance matters. The content is legal and regulatory in nature, focusing on the internal rules and governance structure of the company rather than financial results or announcements. There is no indication that this is an annual report, audit report, earnings release, or any other financial or market disclosure. It is a governance document outlining the company's internal rules and procedures. Therefore, the appropriate classification is Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is the full text of the governance document, not just an announcement or summary.
2025-11-13 Chinese
关于减少注册资本通知债权人的公告
Share Issue/Capital Change Classification · 95% confidence The document is a public announcement by Shanxi Dayu Bioengineering Co., Ltd. regarding the reduction of registered capital due to the cancellation of repurchased shares. It includes details about the board and shareholder approvals, legal compliance, notification to creditors, and instructions for creditors to claim debts within a specified period. The content focuses on capital structure changes and legal notifications to creditors rather than financial results or detailed financial statements. The document length is short (1405 characters), and it is an official announcement about capital reduction and creditor notification, not a full financial report or audit. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2025-10-29 Chinese
2025年第四次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 2025 fourth extraordinary shareholders' meeting of Shanxi Dayu Bioengineering Co., Ltd. It includes details about the meeting date, attendance, voting results on proposals related to share repurchase use change, capital reduction, and amendments to the company charter. It also contains a legal opinion confirming the legality and validity of the meeting and resolutions. The document is not a full report but an official announcement of voting results from a shareholders' meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on voting outcomes, not a full report or presentation.
2025-10-28 Chinese
上海市锦天城律师事务所关于山西大禹生物工程股份有限公司2025年第四次临时股东会的法律意见书
Regulatory Filings Classification · 85% confidence The document is a legal opinion letter from a law firm concerning the convening, procedures, and resolutions of the company’s 4th Extraordinary General Meeting in 2025. It does not present financial statements or actual company filings such as an annual or interim report, nor is it a proxy solicitation or voting notice by the company itself. Instead, it is a compliance/legal opinion certification provided to the company, fitting the criteria for a general regulatory filing. Therefore, the correct classification is Regulatory Filings (RNS).
2025-10-28 Chinese
第四届董事会第七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the seventh meeting of the fourth board of directors of Shanxi Dayu Bioengineering Co., Ltd. It details the meeting attendance, voting results, and references other documents such as the 2025 third quarter report and announcements about business scope changes and shareholder meetings, which are disclosed elsewhere. The document itself does not contain financial statements or detailed financial data but serves as an official notice of board decisions and meeting outcomes. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors or senior management.
2025-10-26 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.